已收盘 12-19 16:00:00 美东时间
+0.160
+1.14%
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从9美元升至10美元;摩根大通:上调Recursion Pharmaceuticals评级至"超配",目标价从10美元升至11美元
12-18 10:54
Itau BBA analyst William Barranjard initiates coverage on DLocal (NASDAQ:DLO) with a Outperform rating and announces Price Target of $21.
12-17 21:01
今日重点评级关注:HC Wainwright & Co.:维持Moleculin Biotech"买入"评级,目标价从4美元升至22美元;HC Wainwright & Co.:上调Soluna Holdings评级至"买入",目标价5美元
12-12 10:24
Truist Securities analyst Matthew Coad upgrades DLocal (NASDAQ:DLO) from Hold to Buy and raises the price target from $15 to $16.
12-12 01:44
dLocal reported Q3 FY25 revenue of $282.5 M, beating estimates, with record $10.4 B total payment volume and 37% gross margin.
11-13 18:35
U.S. stock futures were swinging on Thursday after Wednesday’s mixed moves. Futures of major benchmark indices were mixed.
11-13 18:21
美国政府最快今日结束停摆!道指四连涨首次站上48000点;白宫严正警告!10月CPI与非农或永久缺失;外资看好!全球前40大投资机构的中国股票持仓创两年多新高>>
11-13 08:32
DLocal将于11月12日发布2025年第三季度财报,预期每股收益0.17美元,营收2.65亿美元。财报前看涨期权占比超90%,2026年1月到期、行权价20.47美元的看涨期权成交1.61万张,成交量/持仓比达7.67倍。
11-13 07:21
DLocal (NASDAQ:DLO) sees FY2025 revenue tracking toward upper end of 30–40% YoY growth.
11-13 06:28
DLocal shares are trading lower. The company reported Q3 financial results.
11-13 05:16